ArticleCase reports in neurological medicine2026
A Case of Restless Arm Syndrome and the Effective Use of Gabapentin.
Article in Case reports in neurological medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A Case of Restless Arm Syndrome and the Effective Use of Gabapentin.Case reports in neurological medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Restless arm syndrome (RAS) is an uncommon neurological condition that is characterized by an irresistible urge to move the upper limbs, often worse at rest and transiently relieved by movement. RAS is an upper limb variant of restless legs syndrome (RLS), a more common neurological condition, also known as Willis-Ekbom disease. In view of its atypical presentation, RAS is often underdiagnosed. RAS is reported to share the same risk factors as RLS with its prevalence increasing with age, in the presence of certain conditions, and associated with the use of medications like antipsychotics and antidepressants. A case of possible RAS is described here in a patient who had experienced a few years of RLS-like symptoms and had been on various antidepressants for his depression. His symptoms markedly improved with a trial of gabapentin, which subsequently raised the possibility of RAS as a diagnosis. Clinicians should consider RAS as a differential in patients who experience symptoms suggestive of RLS in the presence of associated risk factors.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.